Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Xenon Pharmaceuticals (NASDAQ:XENE) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Xenon Pharmaceuticals missed estimated earnings by 14.58%, reporting an EPS of $-0.55 versus an estimate of $-0.48.
Revenue was down $1.68 million from the same period last year.
Last quarter the company beat on EPS by $0.06 which was followed by a 5.71% drop in the share price the next day.
Here's a look at Xenon Pharmaceuticals's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.41 | -0.37 | -0.38 | -0.48 |
EPS Actual | -0.35 | -0.48 | -0.36 | -0.51 |
Revenue Estimate | 8.70M | 4.97M | 10.22M | 2.33M |
Revenue Actual | 8.77M | 3.74M | 8.12M | 2.22M |
To track all earnings releases for Xenon Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: XENE